Showing 19,541 - 19,560 results of 42,148 for search '(( 50 ((we decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 1.41s Refine Results
  1. 19541

    Image_3_Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following... by Shardulendra Prasad Sherchand (13108779)

    Published 2022
    “…Therefore, we first optimized an in vitro assay that quantifies recombinant Gmd lysis of the M. luteus cell wall and used it to demonstrate the 50% neutralizing concentration (NC<sub>50</sub>) of a humanized anti-Gmd mAb (TPH-101) to be ~15.6 μg/ml. …”
  2. 19542

    Image_2_Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following... by Shardulendra Prasad Sherchand (13108779)

    Published 2022
    “…Therefore, we first optimized an in vitro assay that quantifies recombinant Gmd lysis of the M. luteus cell wall and used it to demonstrate the 50% neutralizing concentration (NC<sub>50</sub>) of a humanized anti-Gmd mAb (TPH-101) to be ~15.6 μg/ml. …”
  3. 19543

    DataSheet1_Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis.docx by Guanglin Xiao (18113302)

    Published 2024
    “…The random-effects model (when I<sup>2</sup> ≥ 50%) or fixed effect model (I<sup>2</sup> < 50%) was used.…”
  4. 19544

    Combination therapy of high dose PC1, kansui, and JQ1 reactivates latent HIV in a primary CD4+ T cell model of HIV latency. by Daniele C. Cary (3559394)

    Published 2018
    “…At 12 days post infection, cells were stimulated for 24 hours with: (A) PC1 (24 μM) and kansui (50 μg/ml) (B) PC1 (24 μM) and JQ1 (0.1 μM) (C) e PC1 (24 μM), kansui (50 μg/ml), and JQ1 (0.1 μM). …”
  5. 19545

    Combination therapy of low dose PC1, kansui, and JQ1 reactivates latent HIV in a primary CD4+ T cell model of HIV latency. by Daniele C. Cary (3559394)

    Published 2018
    “…At 12 days post infection, cells were stimulated for 24 hours with: (A) single and double PC1 (6 μM) and kansui (50 μg/ml) (B) single and double PC1 (6 μM) and JQ1 (0.1 μM) (C) single and triple PC1 (6 μM), kansui (50 μg/ml), and JQ1 (0.1 μM). …”
  6. 19546

    Table_1_Bolder and Brighter? Exploring Correlations Between Personality and Cognitive Abilities Among Individuals Within a Population of Wild Zebrafish, Danio rerio.DOCX by Danita K. Daniel (9231908)

    Published 2020
    “…In general, the presence of a predator decreased performance latencies. However, bolder individuals were less affected and emerged more quickly from the refuge chamber than shy individuals. …”
  7. 19547

    Data_Sheet_1_The Association of Body Mass Index With Mortality Among Pulmonary Hypertension Patients: A Systematic Review and Meta-Analysis of Cohort Studies.pdf by Chaoxin Jiang (12521914)

    Published 2022
    “…</p>Conclusion<p>Higher BMI is related to decreased risk of mortality among PH patients and the lowest point of the curve was seen at BMI 32–38.…”
  8. 19548

    DataSheet3_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  9. 19549

    DataSheet2_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  10. 19550

    DataSheet1_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  11. 19551

    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results by Jenny Link (166175)

    Published 2017
    “…The previously observed immunogenic difference among the four IFNβ preparations was confirmed in this large dataset. Decreased usage of the more immunogenic preparations IFNβ-1a subcutaneous (s.c.) and IFNβ-1b s.c. in favor of the least immunogenic preparation IFNβ-1a intramuscular (i.m.) was observed. …”
  12. 19552

    Shape rescue in the midface phenotype in the Dp(16)1Yey/ <i>Ripply3</i><sup><i>tm1b</i></sup> compound mutant. by José Tomás Ahumada Saavedra (22290934)

    Published 2025
    “…On the left, the histogram of every point distance evaluated (in this case, more than 1.238.684 points) and the surface differences with the color code for the increase-decrease dimensions (Red to green).…”
  13. 19553
  14. 19554

    Refractive Profiles in Children Receiving School-Based Eye Exams Following Vision Screening from a Large School-Based Vision Program in 2016 to 2022 by Andrew M. Nguyen (20176426)

    Published 2024
    “…Main outcomes included any refractive error (at least −0.50D myopia, +0.50 hyperopia, 1.00D astigmatism, or 1.00D anisometropia), clinically significant refractive error (CSRE; more severe refractive error with decreased vision), and refractive amblyopia risk (RAR). …”
  15. 19555

    Ouabain block of the Na<sup>+</sup>/K<sup>+</sup> pump switches Purkinje cell activity out of the trimodal firing pattern and into a continuous burst mode. by Michael D. Forrest (292801)

    Published 2013
    “…In this case, the only deflections observed are those of the Ca<sup>2+</sup> spikes that have travelled into the soma from the dendritic arborisation (<i>E</i>, <i>I</i>). <i>Panel A scaling is encoded in the first scale bar (50 mV, 50 s). …”
  16. 19556
  17. 19557
  18. 19558
  19. 19559
  20. 19560